Search results
Myriad (MYGN) Down 5.2% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 12 hours agoIt has been about a month since the last earnings report for Myriad Genetics (MYGN). Shares have...
Myriad Genetics director Daniel K. Spiegelman sells shares worth over $167k By Investing.com
Investing.com· 2 days agoDaniel K. Spiegelman, a director at Myriad Genetics Inc. (NASDAQ:MYGN), has sold a total of 7,576...
Insider Sale: Director Daniel Spiegelman Sells Shares of Myriad Genetics Inc (MYGN)
GuruFocus.com via Yahoo Finance· 2 days agoOn June 4, 2024, Daniel Spiegelman, Director at Myriad Genetics Inc (NASDAQ:MYGN), executed a sale...
Qiagen, Myriad Genetics to Develop Sequencing-Based Homologous Recombination Deficiency Kit
GenomeWeb News· 7 days agoQiagen and Myriad Genetics announced on Thursday that they have agreed to develop a globally distributable kit-based test for analyzing homologous recombination ...
Insider Sale Alert: Myriad Genetics, Inc. [MYGN] – Is it Time to sell? – Knox Daily
Knox Daily· 3 days agoMyriad Genetics, Inc.’s filing revealed that its President and CEO DIAZ PAUL J unloaded Company’s shares for reported $1.88 million on May 15 ’24. In the ...
QIAGEN (QGEN) Develops Test for Research and CDx Application
Zacks via Yahoo Finance· 7 days agoQIAGEN's (QGEN) next-generation sequencing test aims to aid personalized medicine research in solid...
Lymphadenectomy Not Needed in Advanced Ovarian Cancer With Optimal Surgery
MedPage Today· 4 days agoOmitting lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or...
QIAGEN's (QGEN) New Launch Expands US Syndromic Testing Menu
Zacks via Yahoo Finance· 2 days agoOther Developments in the Molecular Diagnostics Business Last week, QIAGEN, together with Myriad ...
Best Buy upgraded, Target initiated: Wall Street's top analyst calls
The Fly via Yahoo Finance· 4 days agoJefferies sees a host of headwinds for growth tools and awaits more visibility, and is upbeat on the...
Labs, Doctors Still Grapple With Patient Recontact Despite Streamlined Variant Reclassification
GenomeWeb News· 7 days agoAlmost four years after the ruling in favor of Quest Diagnostics in one of the most notable genetic...